|
Market Closed -
Other stock markets
|
After hours 19:56:48 | |||
| 120.60 USD | +1.83% |
|
123.53 | +2.43% |
| 08-03 | Mizuho Adjusts Price Target on Incyte to $137 From $121 | MT |
| 08-03 | Leerink Partners Adjusts Price Target on Incyte to $155 From $131, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | +1.83% | -7.18% | +22.10% | +54.54% | +55.93% | 24.01B |  |  | |
- Stock Market
- Stocks
- INCY Stock
- Charts Incyte Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
